Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the chronic lower back pain market grown in recent years?

The market size of chronic lower back pain has seen a consistent growth over the recent years. The market which is projected to be at $7.72 billion in 2024, is expected to escalate to $8.08 billion in 2025, showing a compound annual growth rate (CAGR) of 4.6%. The growth during the historic period is primarily due to factors such as a rise in sedentary lifestyles, risks associated with manual labor and occupations, advancements in medical diagnosis, evolution of pain management, and epidemiological research.

How is the chronic lower back pain market size expected to evolve during the forecast period?

The market for chronic lower back pain is projected to experience significant expansion in the upcoming years, ballooning to $9.99 billion by 2029 with a compound annual growth rate (CAGR) of 5.5%. This robust growth during the forecast period can be linked to factors such as the increase in non-pharmacological treatments, initiatives promoting preventive healthcare, interest in comprehensive healing methods, advancements in regenerative medicine, and trends relating to an aging population. Key trends for the forecast period encompass emphasis on non-pharmacological treatments, changes in pain management strategies, heightened cognizance and education in healthcare, the adoption of telemedicine and remote monitoring, and the incorporation of regenerative medicine.

Get your chronic lower back pain market report here!

https://www.thebusinessresearchcompany.com/report/chronic-lower-back-pain-global-market-report

Which key drivers are propelling the chronic lower back pain market’s growth?

The chronic lower back pain market is projected to flourish due to an expected rise in nerve instance frequency. In this context, nerve instances refer to particular episodes or conditions in which individuals exhibit bravery, grit or resilience in challenging or overwhelming situations. Prolonged exposure to pain and stress may result in a condition known as central sensitization, where the nervous system becomes oversensitive, and pain is felt more sharply, regardless of the existence of an actual injury. For example, Nature, a British weekly scientific journal, reported in July 2023 that peripheral neuropathy, linked with nerve damage, had a prevalence rate of 28.4% in adults over 40 years of age with diabetes and 11.8% in those without diabetes. Hence, this rise in nerve instance frequency is contributing to the growth in the chronic lower back pain market.

What are the market segments in the chronic lower back pain industry?

The chronic lower back pain market covered in this report is segmented –

1) By Type Of Pain: Diskogenic Pain, Lumbar Spinal Stenosis, Sacroiliac Pain, Facet-Joint Pain, Radicular Pain, Muscular Pain, Other Types Of Pain

2) By Diagnosis: Clinical History, Physical Examination, Imaging Guidelines, Assessment Of Pain

3) By End-User: Hospitals, Orthopedic Clinics, Ambulatory Surgery Centers, Other End-Users

Subsegments:

1) By Diskogenic Pain: Herniated Disc, Degenerative Disc Disease, Disc Bulge, Lumbar Spinal Stenosis

2) By Lumbar Spinal Stenosis: Central Stenosis, Lateral Stenosis

3) By Sacroiliac Pain: Sacroiliac Joint Dysfunction, Inflammatory Conditions

4) By Facet-Joint Pain: Facet Joint Syndrome, Osteoarthritis Of The Facet Joints

5) By Radicular Pain: Sciatica, Nerve Root Compression

6) By Muscular Pain: Muscle Strain, Muscle Spasm

7) By Other Types of Pain: Myofascial Pain Syndrome, Spondylolisthesis, Osteoporosis-Related Pain

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9946&type=smp

Which leading companies are shaping the growth of the chronic lower back pain market?

Major companies operating in the chronic lower back pain market include Pfizer Inc., Johnson & Johnson Private Limited, Sanofi S.A., Endo Pharmaceuticals plc, Merck Corporation, Vertebral Technologies Inc., Medtronic plc, Boston Scientific Corporation, BioWave Corporation, Koninklijke Philips N.V., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., SpineThera Inc., Dr. Reddy’s Laboratories Ltd., Celgene Corporation, Axsome Therapeutics Inc., Mesoblast Limited, Frontier Biotechnologies Inc., Eli Lilly and Company, Persica Pharmaceuticals, Abbott Laboratories, Hisamitsu Pharmaceutical Co. Inc., Ipsen S.A., Daiichi Sankyo Company Ltd., Zimmer Biomet Holdings Inc., Novartis International AG, Janssen Pharmaceuticals Inc., Insys Therapeutics Inc., Collegium Pharmaceutical Inc., Cara Therapeutics Inc.

What key trends are currently impacting the chronic lower back pain market’s development?

Companies leading the chronic lower back pain market are putting a focus on the development of innovative pharmaceuticals to aid their clients and secure their market position. The creation of novel drugs has the potential to enhance the results of patient treatments for a range of health conditions. For example, Amneal Pharmaceuticals, an American pharmaceutical company, in July 2022, introduced LYVISPAH, an FDA approved baclofen oral granule (5, 10, and 20 mg), for managing spasticity related to multiple sclerosis and various spinal cord disorders. This product facilitates the treatment and relief of flexor spasms, associated pain, clones, and muscular stiffness. LYVISPAH offers adjustable and bespoke dosing with individual dose packets of granules with doses of 5 mg, 10 mg, and 20 mg, and it mirrors the bioequivalence of oral baclofen tablets. Patients suffering from spinal cord injuries and other spinal cord issues might find LYVISPAH to be beneficial.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9946

Which geographic areas are influencing the growth of the chronic lower back pain market?

North America was the largest region in the chronic lower back pain market in 2024. The regions covered in the chronic lower back pain market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Product Engineering Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/product-engineering-services-global-market-report

Professional Services Global Market Opportunities And Strategies To 2032

https://www.thebusinessresearchcompany.com/report/professional-services-market

Ventricular Assist Device Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/ventricular-assist-device-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: